Aesthetic Medical International Holdings Group Business Summary

Aesthetic Medical International Holdings Group Ltd (PAIYY), operating under the brand "Peng’ai," is a vertically integrated provider of aesthetic medical services in the People’s Republic of China. The company generates revenue through a transaction-based model across three primary segments: non-surgical aesthetic medical services (minimally invasive and energy-based treatments), surgical aesthetic treatments (including rhinoplasty and breast augmentation), and general healthcare services. As of early 2026, the firm has strategically pivoted to prioritize its non-surgical portfolio to capitalize on higher margins and lower recovery times, leveraging a network of treatment centers concentrated in the Greater Bay Area and Yangtze River Delta. In the competitive landscape, the company faces intense rivalry from online-to-offline (O2O) platforms like So-Young International (SY), which has expanded into self-operated clinics, as well as diversified giants such as Meituan and Alibaba Health. Within this market, PAIYY distinguishes itself as an established, clinical-first operator with over two decades of institutional experience compared to newer, platform-centric entrants. The leadership team is anchored by co-founder Dr. Zhou Pengwu, who serves as Chief Executive Officer and Chairman, bringing over 30 years of clinical experience as a registered plastic surgeon. He is supported by co-founder and Vice-chairwoman Ding Wenting, who oversees marketing strategy, and Chief Operating Officer Hu Qing, who manages the group’s extensive clinic network. The executive board was further strengthened by the appointment of Zhang Chen as Executive Co-Chairman, representing the interests of major investor Lafang China Co., Ltd. Other key leadership figures include Chief Financial Officer Fan Peng and Independent Director Chen Feng, a Vice President at ADV Partners. Notable institutional backing includes ADV Partners, Shenzhen Capital Group, and Lafang China, reflecting a stable investor base that has supported the company’s transition from a Nasdaq listing to the OTCQX Best Market.